- Home
- BSX vs APP Comparison
BSX vs APP Comparison
Compare BSX & APP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- APP
- Stock Information
- Founded
- BSX 1979
- APP 2012
- Country
- BSX United States
- APP United States
- Employees
- BSX N/A
- APP N/A
- Industry
- BSX Medical/Dental Instruments
- APP EDP Services
- Sector
- BSX Health Care
- APP Technology
- Exchange
- BSX Nasdaq
- APP Nasdaq
- Market Cap
- BSX 157.6B
- APP 158.0B
- IPO Year
- BSX 1992
- APP 2021
- Fundamental
- Price
- BSX $102.70
- APP $582.00
- Analyst Decision
- BSX Strong Buy
- APP Buy
- Analyst Count
- BSX 22
- APP 21
- Target Price
- BSX $118.91
- APP $472.50
- AVG Volume (30 Days)
- BSX 6.6M
- APP 6.1M
- Earning Date
- BSX 10-22-2025
- APP 11-05-2025
- Dividend Yield
- BSX N/A
- APP N/A
- EPS Growth
- BSX 36.90
- APP 198.85
- EPS
- BSX 1.68
- APP 7.03
- Revenue
- BSX $18,494,000,000.00
- APP $5,737,591,000.00
- Revenue This Year
- BSX $19.75
- APP $19.64
- Revenue Next Year
- BSX $10.98
- APP $30.12
- P/E Ratio
- BSX $61.13
- APP $79.98
- Revenue Growth
- BSX 21.44
- APP 78.91
- 52 Week Low
- BSX $80.64
- APP $97.35
- 52 Week High
- BSX $109.50
- APP $587.88
- Technical
- Relative Strength Index (RSI)
- BSX 38.78
- APP 80.20
- Support Level
- BSX $104.24
- APP $560.79
- Resistance Level
- BSX $109.50
- APP $511.00
- Average True Range (ATR)
- BSX 1.90
- APP 20.45
- MACD
- BSX -0.35
- APP 9.01
- Stochastic Oscillator
- BSX 3.13
- APP 96.18
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About APP Applovin Corporation
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.